Advances in immunology, a focus on human tissue and a dash of luck have given dermatologists several highly effective psoriasis therapies, of which Stelara is the latest. Ken Garber reports.
This is a preview of subscription content, log in via an institution to check access.
References
Benson, J.M. et al. Nat. Biotechnol. 29, 615–624 (2011).
Lee, E. et al. J. Exp. Med. 199, 125–130 (2004).
Lowes, M.A. et al. J. Invest. Dermatol. 128, 1207–1211 (2008).
Cargill, M. et al. Am. J. Hum. Genet. 80, 273–290 (2007).
Nair, R.P. et al. Nat. Genet. 41, 199–204 (2009).
Tonel, G. et al. J. Immunol. 185, 5688–5691 (2010).
Hueber W. et al. Sci. Transl. Med. 2, 52raa72 (2010).
Russell C.B. et al., J. Invest. Dermatol. 130, S46, abstract 273 (2010).
Chiricozzi, A. et al. J. Invest. Dermatol. 131, 677–687 (2011).
Reich, K. et al. Br. J. Dermatol. 164, 862–872 (2011).
Griffiths, C.E. et al. N. Engl. J. Med. 362, 118–128 (2010).
Garber, K. Nat. Biotechnol. 29, 467–468 (2011).
Ghoreschi, K. et al. J. Immunol. 186, 4234–4243 (2011).
Boy, M.G. et al. J. Invest. Dermatol. 129, 2299–2302 (2009).
Ellinghaus, E. et al. Nat. Genet. 42, 991–995 (2010).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. Psoriasis: from bed to bench and back. Nat Biotechnol 29, 563–566 (2011). https://doi.org/10.1038/nbt.1906
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1906
- Springer Nature America, Inc.
This article is cited by
-
Anti-IL-17 mAbs herald new options in psoriasis
Nature Biotechnology (2012)
-
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Nature Genetics (2012)
-
Evaluation of SLOG/TCI-III pediatric system on target control infusion of propofol
Journal of Translational Medicine (2011)